Factors associated with improvement or decline in cognitive function after an ischemic stroke in Korea: the Korean stroke cohort for functioning and rehabilitation (KOSCO) study

Jin A Yoon, Deog Young Kim, Min Kyun Sohn, Jongmin Lee, Sam-Gyu Lee, Yang-Soo Lee, Eun Young Han, Min Cheol Joo, Gyung-Jae Oh, Junhee Han, Minsu Park, Kyung Pil Park, Kyung-Ha Noh, Won Hyuk Chang, Yong-Il Shin, Yun-Hee Kim, Jin A Yoon, Deog Young Kim, Min Kyun Sohn, Jongmin Lee, Sam-Gyu Lee, Yang-Soo Lee, Eun Young Han, Min Cheol Joo, Gyung-Jae Oh, Junhee Han, Minsu Park, Kyung Pil Park, Kyung-Ha Noh, Won Hyuk Chang, Yong-Il Shin, Yun-Hee Kim

Abstract

Background: We conducted a prospective cohort study to investigate prevalence of poststroke cognitive impairment at 3 and 12 months after stroke onset and identify clinical and demographic factors associated with improvement or decline in cognitive function between 3 months and 12 months.

Methods: We analyzed the cognitive assessments of total patients and patients older than 65 years separately. All patients with an ischemic stroke were divided into normal cognitive group (NCG) and impaired cognition group (ICG) by using a cutoff score on the Korean Mini-Mental State Examination (K-MMSE). Patients were additionally classified into 3 subgroups according to the changes in their K-MMSE scores between 3 and 12 months: Stable group with K-MMSE scores changes ranging from -2 to +2 points (-2 ≤ △MMSE ≤ +2); converter group with increase more than 3 points (3 ≤ △MMSE); and reverter group with decrease more than 3 points (-3 ≤ △MMSE). We also analyzed factors affecting cognitive change from 3 months to 12 months among the 3 groups including baseline medical record, stroke and treatment characteristics, and various functional assessments after 3 months.

Results: This study included 2,625 patients with the first time ischemic stroke. Among these patients, 1,735 (66.1%) were classified as NCG, while 890 patients (33.9%) were belonged to the ICG at 3 month. Within the NCG, 1,460 patients (82.4%) were stable group, 93 patients (5.4%) were converter group, and 212 patients (12.2%) were reverter group at 12 months onset. Within the ICG group, 472 patients (53.0%) were stable group, 321 patients (36.1%) were converter group, and 97 patients (10.9%) were reverter group. When different factors were investigated, the three subgroups in NCG and ICG showed significant different factors affecting cognitive function from 3 to 12 month.

Conclusions: The prevalence of cognitive impairment showed difference between 3,12 months. To analyze the cognitive change from 3 month to 12 month, the proportion stable group was dominant in NCG and converter group was higher in ICG. By investigating the influencing factors from each group, we were able to identify the predictors including the age factor.

Keywords: Cognition; Inverter; Ischemic stroke; Reverter; Risk factors.

Figures

Fig. 1
Fig. 1
Flow diagram of this study
Fig. 2
Fig. 2
Cognitive function of patients at 3 months and 12 months after stroke onset
Fig. 3
Fig. 3
Cognitive change of total patients from 3 months to 12 months
Fig. 4
Fig. 4
Cognitive change of the older patient group from 3 months to 12 months

References

    1. Hebert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology. 1995;14:240–257. doi: 10.1159/000109800.
    1. Leys D, Pasquier F, Parnetti L. Epidemiology of vascular dementia. Haemostasis. 1998;28:134–150.
    1. Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med. 1993;328:153–158. doi: 10.1056/NEJM199301213280301.
    1. de Haan R, Limburg M, Van der Meulen J, Jacobs H, et al. Quality of life after stroke impact of stroke type and lesion location. Stroke. 1995;26:402–408. doi: 10.1161/01.STR.26.3.402.
    1. Pohjasvaara T, Erkinjuntti T, Ylikoski R, Hietanen M, et al. Clinical determinants of poststroke dementia. Stroke. 1998;29:75–81. doi: 10.1161/01.STR.29.1.75.
    1. Tatemichi TK, Foulkes MA, Mohr JP, Hewitt JR, Hier DB, Price TR, Wolf PA. Dementia in stroke survivors in the stroke data bank cohort: prevalence, incidence, risk factors, and computed tomographic findings. Stroke. 1990;21:858–866. doi: 10.1161/01.STR.21.6.858.
    1. He’non H, Pasquier F, Durieu I, Godefroy O, Lucas C, Lebert F, Leys D. Preexisting dementia in stroke patients: baseline frequency, associated factors, and outcome. Stroke. 1997;28:2429–2436. doi: 10.1161/01.STR.28.12.2429.
    1. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci. 1970;11:205–242. doi: 10.1016/0022-510X(70)90063-8.
    1. Katzman R. Vascular disease and dementia. In: Yahr MD, editor. H. Houston Merritt memorial volume. New York: Raven; 1983. pp. 153–176.
    1. Madureira S, Guerreiro M, Ferro JM. Dementia and cognitive impairment three months after stroke. Eur J Neurol. 2001;8:621–27. doi: 10.1046/j.1468-1331.2001.00332.x.
    1. Henon H, Durieu I, Guerouaou D, Lebert F, Pasquier F, Leys D. Poststroke dementia: incidence and relationship to prestrike cognitive decline. Neurology. 2001;57:1216–22. doi: 10.1212/WNL.57.7.1216.
    1. Inzitari D, Di Carlo A, Pracucci G, Lamassa M, Vanni P, Romanelli M, et al. Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry. Stroke. 1998;29:2087-93.
    1. Henon H, Pasquier F, Leys D. Poststroke dementia. Cerebrovasc Dis. 2006;22:61–70. doi: 10.1159/000092923.
    1. Snaphaan L, de Leeuw FE. Poststroke memory function in nondemented patients: a systematic review on frequency and neuroimaging correlates. Stroke. 2007;38:198–203. doi: 10.1161/01.STR.0000251842.34322.8f.
    1. Desmond DW, Moroney JT, Sano M, Stern Y. Recovery of cognitive function after stroke. Stroke. 1996;27:1798–1803. doi: 10.1161/01.STR.27.10.1798.
    1. Tham W, Auchus AP, Thong M, Goh M-L, Chang H-M, Wong M-C, Chen C. Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. J Neurol Sci. 2002;203–204:49–52. doi: 10.1016/S0022-510X(02)00260-5.
    1. Ballard C, Rowan E, Stephens S, Kalaria R, Kenny RA. Prospective follow-up study between 3 and 15 months after stroke improvements and decline in cognitive function among dementia-free stroke survivors >75 years of Age. Stroke. 2003;34:2440–2445. doi: 10.1161/01.STR.0000089923.29724.CE.
    1. Lowery K, Ballard C, Rodgers H, McLaren A, O’Brien J, Rowan E, Stephens S. Cognitive decline in a prospectively studied group of stroke survivors, with a particular emphasis on the 75’s. Age Ageing. 2002;31(suppl 3):24–27. doi: 10.1093/ageing/31.suppl_3.24.
    1. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M. Clinical determinants of post-stroke dementia in the Helsinki stroke aging memory study (SAM) cohort. Stroke. 1997;28:785–792. doi: 10.1161/01.STR.28.4.785.
    1. Chang WH, Sohn MK, Lee J, et al. Korean stroke cohort for functioning and rehabilitation (KOSCO): study rationale and protocol of a multi-centre prospective cohort study. BMC Neurol. 2015;15:42. doi: 10.1186/s12883-015-0293-5.
    1. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke. Stroke. 2006;37:1583–1633. doi: 10.1161/01.STR.0000223048.70103.F1.
    1. Bernardini J, Callen S, Fried L, Piraino B. Inter-rater reliability and annual rescoring of the Charlson comorbidity index. Adv Perit Dial. 2004;20:125–127.
    1. Oh MS, Yu KH, Lee JH, Jung S, Ko IS, Shin JH, et al. Validity and reliability of a Korean version of the national institutes of health stroke scale. J Clin Neurol. 2012;8:177–83. doi: 10.3988/jcn.2012.8.3.177.
    1. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. Classification of stroke subtypes. Cerebrovasc Dis. 2009;27:493–501. doi: 10.1159/000210432.
    1. Kang Y, Na DL, Hahn S. A validity study on the Korean mini-mental state examination (K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997;15:300–8.
    1. Dodds TA, Martin DP, Stolov WC, Deyo RA. A validation of the functional independence measurement and its performance among rehabilitation inpatients. Arch Phys Med Rehabil. 1993;74:531–6. doi: 10.1016/0003-9993(93)90119-U.
    1. Jung HY, Park BK, Shin HS, Kang YK, Pyun SB, Paik NJ, et al. Development of the Korean version of modified barthel index (K-MBI): multi-center study for subjects with stroke. J Korean Acad Rehabil Med. 2007;31:283–97.
    1. Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. 1. A method for evaluation of physical performance. Scand J Rehabil Med. 1975;7:13–31.
    1. Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness Phys Ther. 1984;64:35–40.
    1. Burn JP. Reliability of the modified Rankin scale. Stroke. 1992;23:438.
    1. Lesher EL, Berryhill JS. Validation of the geriatric depression scale–short form among inpatients. J Clin Psychol. 1994;50:256–60. doi: 10.1002/1097-4679(199403)50:2<256::AID-JCLP2270500218>;2-E.
    1. Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ. 2005;6:124–30. doi: 10.1007/s10198-004-0264-z.
    1. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associatted with pre-stroke and poststroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009;8(11):1006–18.
    1. Inzitari D, Di Carlo A, Pracucci G, Lamassa M, Vanni P, Romanelli M, Spolveri S, Adriani P, Meucci I, Landini G, Ghetti A. Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry. Stroke. 1998;29:2087–2093. doi: 10.1161/01.STR.29.10.2087.
    1. Desmond DW, Moroney JT, Paik MC. Frequency and clinical determinants of dementia after ischemic stroke. Neurology. 2000;54:1124–1131. doi: 10.1212/WNL.54.5.1124.
    1. Barba R, Martinez ES, Rodriguez GE, Pondal M, Vivancos J, Del Ser T. Poststroke dementia: clinical features and risk factors. Stroke. 2000;31:1494–1501. doi: 10.1161/01.STR.31.7.1494.
    1. Tatemichi TK, Desmond DW, Paik M, et al. The mini-mental state examination as a screen for dementia following stroke [abstract] J Clin Exp Neuropsychol. 1991;13:419.
    1. Tsoi K, Chan J, Hirai H, Wong S, Kwok T. Cognitive tests to detect dementia a systematic review and meta-analysis. JAMA Intern Med. 2015;175:1450–1458. doi: 10.1001/jamainternmed.2015.2152.
    1. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6.
    1. Kim YJ, Han JW, So YS, Seo JY, Kim KY, Kim KW. Prevalence and trends of dementia in Korea: a systematic review and meta-analysis. J Korean Med Sci. 2014;29:903–912. doi: 10.3346/jkms.2014.29.7.903.
    1. Alzheimer’s Disease International. World Alzheimer’s report 2009. London: Alzheimer’s Disease International, 2009. p. 26.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever